Swiss National Bank Acquires 24,100 Shares of The Clorox Company $CLX

Swiss National Bank lifted its holdings in shares of The Clorox Company (NYSE:CLX) by 7.2% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 357,900 shares of the company’s stock after purchasing an additional 24,100 shares during the period. Swiss National Bank’s holdings in Clorox were worth $37,089,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the business. Annis Gardner Whiting Capital Advisors LLC bought a new position in shares of Clorox during the 1st quarter worth approximately $182,000. Assetmark Inc. increased its stake in shares of Clorox by 16.6% in the 1st quarter. Assetmark Inc. now owns 11,791 shares of the company’s stock valued at $1,222,000 after acquiring an additional 1,678 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its position in shares of Clorox by 3.5% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 5,237 shares of the company’s stock valued at $546,000 after acquiring an additional 177 shares during the period. Independent Financial Group LLC acquired a new position in shares of Clorox during the 1st quarter valued at $420,000. Finally, Wealthfront Advisers LLC boosted its stake in Clorox by 18.5% during the first quarter. Wealthfront Advisers LLC now owns 3,690 shares of the company’s stock worth $382,000 after acquiring an additional 575 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, Director Pierre R. Breber acquired 5,000 shares of the business’s stock in a transaction on Tuesday, May 5th. The shares were purchased at an average cost of $85.82 per share, with a total value of $429,100.00. Following the acquisition, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.63% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on CLX. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $94.00 price target on shares of Clorox in a research note on Wednesday. Barclays upped their target price on Clorox from $85.00 to $86.00 and gave the stock an “underweight” rating in a research report on Tuesday. UBS Group lifted their price target on shares of Clorox from $96.00 to $100.00 and gave the company a “neutral” rating in a research report on Thursday, July 16th. Jefferies Financial Group decreased their price target on shares of Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Finally, Zacks Research downgraded shares of Clorox from a “hold” rating to a “strong sell” rating in a report on Tuesday, May 12th. One investment analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the stock. Based on data from MarketBeat, Clorox currently has an average rating of “Reduce” and an average target price of $103.60.

Clorox Stock Performance

Shares of Clorox stock opened at $95.72 on Thursday. The company has a market cap of $11.57 billion, a PE ratio of 15.54 and a beta of 0.54. The Clorox Company has a 52 week low of $84.70 and a 52 week high of $132.03. The business has a 50 day moving average price of $94.94 and a 200-day moving average price of $103.94. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter in the previous year, the firm earned $1.45 earnings per share. Clorox’s quarterly revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities analysts anticipate that The Clorox Company will post 5.52 earnings per share for the current fiscal year.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.